Company Name or Ticker Symbol
Search for other Categories

Orgenesis Inc.  (ORGS)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs

ORGS's Net Income Year on Year Growth by Quarter and Year

Orgenesis's Net Income results by quarter and year

Select the Comparisons : Select the Ratio:                        
ORGS Net Income (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter November - 9.19 2.57 6.26
III Quarter August - - - -3.49
II Quarter May 0.56 - 1.10 1.80
I Quarter February -9.00 - 0.79 1.72
FY   -8.44 9.19 4.46 6.29

Financial Statements
Orgenesis's second quarter 2017 Net Income $ 0.56 millions ORGS's Income Statement
Orgenesis's second quarter 2016 Net Income $ 0.00 millions Quarterly ORGS's Income Statement
ORGS's Growth by Division See ORGS's Growth by Segment

ORGS Net Income ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter November - 257.59 % -58.95 % 565.96 %
III Quarter August - - - -
II Quarter May - - -38.89 % 35.34 %
I Quarter February - - -54.07 % -47.4 %
FY   - 106.05 % -29.09 % -

ORGS Net Income Growth Comment
Orgenesis Inc. in the second quarter achieved Net Income of $ 0.56 millions compare to net loss recorded in same quarter a year ago.

According to the results reported in the second quarter, Orgenesis Inc. achieved the best Net Income growth in Biotechnology & Drugs industry. While Orgenesis Inc.' s Net Income no change of % ranks overall at the positon no. 3 in the second quarter.

Net Income Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #1
Healthcare Sector #1
Overall #3
Net Income Y/Y Growth Statistics
High Average Low
14262.8 % 1326.27 % -99.97 %
(May 31 2017)   (Feb 29 2016)

You need to upgrade your Flash Player

Other Net Income Growth
Biotechnology & Drugs Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
ORGS's Net Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for ORGS's Competitors
Net Income Growth for Orgenesis's Suppliers
Net Income Growth for ORGS's Customers

You may also want to know
ORGS's Annual Growth Rates ORGS's Profitability Ratios ORGS's Asset Turnover Ratio ORGS's Dividend Growth
ORGS's Roe ORGS's Valuation Ratios ORGS's Financial Strength Ratios ORGS's Dividend Payout Ratio
ORGS's Roa ORGS's Inventory Turnover Ratio ORGS's Growth Rates ORGS's Dividend Comparisons

Companies with similar Net Income no change for the quarter ending May 31 2017 within Healthcare SectorY/Y Change %Net Income for the quarter ending May 31 2017
Oramed Pharmaceuticals Inc. -1.55 %$ -1.553 millions
Cryo Cell International Inc -22.00 %$ -22.004 millions


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

CRDE's Profile

Stock Price

CRDE's Financials

CRDE's Expectations

Business Description


Charts & Quotes

CRDE's News


CRDE's Competitors

Customers & Markets

Economic Indicators

CRDE's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength



Management Effectivness


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com